A federal vaccine advisory committee will consider whether the FDA should approve the mRNA vaccine for use in older adults.
A new study finds that people experience symptoms months after travel-related vector-borne infections, but they eventually resolve.
A 2023 outbreak of locally acquired cases infected 10 people across 4 states.
A WHO report finds that progress on global health challenges has slowed, stalled, or even reversed.
Among those with a delayed diagnosis, 51% go on to develop severe malaria.
The findings show that substantial reductions in deaths are possible even when only moderate levels of malaria vaccine coverage can be reached, the authors say.
The malaria drug is a small interfering molecule that binds to and snips RNA molecules so that cells make less of the prion protein.
Countries with high malaria burdens face growing challenges in the wake of the dismantling of USAID.
A study shows cognitive deficits up to 15 years after initial illness.
New research warns of growing insecticide resistance among mosquitoes, the primary vector of malaria in South America.
